Searched for
LIPID NANOPARTICLE TECHNOLOGY
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.- US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhangModerna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possibl...
- Eli Lilly bets on next-generation cell therapy with $2.4 billion deal for OrnaEli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to gen...
- James Bond gadgets: How 007's fiction inspired real-world scienceJames Bond's gadgets, introduced in Dr. No, have significantly influenced pop culture and real-world espionage. From jetpacks in Thunderbal...
- Cancer cure found? Scientists create a new mRNA vaccine that triggers strong anticancer immune response against tumoursUniversity of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat tumors in conjunc...
- mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trialsAustralian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...
- CEPI to fund Gennova's self amplifying mRNA vaccine against Disease XThe Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...
- Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
- VAV Lifesciences to supply key COVID vaccine ingredient to Pfizer, ModernaMumbai-based VAV Lifesciences is the only domestic firm in the COVID-19 vaccine supply chain with this crucial ingredient. It can thus can ...
- Chinese COVID-19 vaccine candidate produces immune response in animals: StudyA COVID-19 vaccine candidate currently undergoing early-stage human trials in China can produce a "robust" immune response against the nove...
Load More
